Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (UP0) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

UP0 Analyst Ratings

Moderate Buy
20Ratings
9Buy11Hold0Sell
Based on 20 analysts giving stock ratings to Ultragenyx Pharmaceutical in the past 3 months

UP0 Stock 12 Month Forecast

€22.59▲(54.96% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Ultragenyx Pharmaceutical in the last 3 months. The average price target is EUR 22.59 with a high forecast of EUR 35.38 and a low forecast of EUR 14.52. The average price target represents a 54.96% change from the last price of EUR 14.58.
Highest Price Target€35.38Average Price Target€22.59Lowest Price Target€14.52

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:UP0
Price TargetArticle
Morgan Stanley€19.96hold36.94%UpsideReiterated11/16/26
H.C. Wainwright€22.68buy55.62%UpsideReiterated11/06/26
Citi€29.03→€19.96buy36.94%UpsideReiterated11/06/26
Barclays€31.75→€29.03buy99.19%UpsideReiterated11/05/26
Piper Sandler€32.66buy124.09%UpsideReiterated11/05/26
Leerink Partners€29.94buy105.42%UpsideReiterated11/05/26
Bank of America Securities€18.15hold24.49%UpsideReiterated11/04/26
Goldman Sachs€17.24→€15.42hold5.82%UpsideReiterated11/04/26
Canaccord Genuity€35.38→€30.85buy111.64%UpsideReiterated11/04/26
Wedbush€22.68→€19.96hold36.94%UpsideReiterated11/04/26
RBC Capital€17.24hold18.27%UpsideReiterated11/04/26
TD Cowen€16.33→€17.24buy18.27%UpsideReiterated11/04/26
Wells Fargo€16.33→€17.24hold18.27%UpsideReiterated11/03/26
Cantor Fitzgerald€35.38buy142.76%UpsideReiterated11/03/26
UBS€14.52hold-0.40%DownsideInitiated10/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ultragenyx Pharmaceutical

3 Months
Success Rate10/18 ratings generated profit
56%
Average Return
+2.11%

Copying Yigal Nochomovitz's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +2.11% per trade.

1 Year
Whitney Ijem
Whitney IjemCanaccord Genuity
Success Rate6/19 ratings generated profit
32%
Average Return
-11.18%

Copying Whitney Ijem's trades and holding each position for 1 Year would result in 31.58% of your transactions generating a profit, with an average return of -11.18% per trade.

2 Years
Yaron Werber
Yaron WerberTD Cowen
Success Rate6/32 ratings generated profit
19%
Average Return
-25.91%

Copying Yaron Werber's trades and holding each position for 2 Years would result in 18.75% of your transactions generating a profit, with an average return of -25.91% per trade.

UP0 Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for UP0
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy1424363722
Buy47863
Hold46222226
Sell00000
Strong Sell00000
total2237666551

In the current month, UP0 has received 25 Buy Ratings, 26 Hold Ratings, and 0 Sell Ratings. UP0 average Analyst price target in the past 3 months is 22.59.

UP0 Financial Forecast

€-3€-1.5€0€1.5€3Q1 2026Q3 2026Q4 2026
High€2.68
Consensus€2.16
Low€1.89

UP0 Earnings Forecast

Next quarter’s earnings estimate for UP0 is EUR 2.16 with a range of EUR 1.89 to EUR 2.68. The previous quarter’s EPS was -EUR 1.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€122.9M€146.2M€169.5M€192.8M€216MQ1 2026Q3 2026Q4 2026
High€216M
Consensus€205M
Low€184M

UP0 Sales Forecast

Next quarter’s sales forecast for UP0 is EUR 204.85M with a range of EUR 184.40M to EUR 216.04M. The previous quarter’s sales results were EUR 156.38M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

UP0 Stock Forecast FAQ

What is DE:UP0’s average 12-month price target, according to analysts?
Based on analyst ratings, Ultragenyx Pharmaceutical’s 12-month average price target is €22.59.
What is DE:UP0’s upside potential, based on the analysts’ average price target?
Ultragenyx Pharmaceutical has 54.96% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
Ultragenyx Pharmaceutical has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 11 hold ratings and 0 sell ratings.
What is Ultragenyx Pharmaceutical’s share price target?
The average share price target for Ultragenyx Pharmaceutical is €22.59. This is based on 20 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €35.38, and the lowest forecast is €14.52. The average share price target represents a 54.96% increase from the current price of €14.575.
What do analysts say about Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Street analysts.
How can I buy shares of Ultragenyx Pharmaceutical?
To buy shares of DE:UP0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.